BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 8963434)

  • 1. Differential effects of an L-type Ca2+ channel antagonist on activity- and phosphorylation-enhanced release of acetylcholine at the neuromuscular junction of the frog in vitro.
    Arenson MS; Gill DS
    Eur J Neurosci; 1996 Mar; 8(3):437-45. PubMed ID: 8963434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of protein kinase C increases acetylcholine release from frog motor nerves by a direct action on L-type Ca(2+) channels and apparently not by depolarisation of the terminal.
    Arenson MS; Evans SC
    Neuroscience; 2001; 104(4):1157-64. PubMed ID: 11457598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iberiotoxin-induced block of Ca2+-activated K+ channels induces dihydropyridine sensitivity of ACh release from mammalian motor nerve terminals.
    Flink MT; Atchison WD
    J Pharmacol Exp Ther; 2003 May; 305(2):646-52. PubMed ID: 12606686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acceleration by stannous ion of the evoked release of transmitter from motor nerve endings in the frog.
    Hattori T; Maehashi H
    Brain Res; 1988 Nov; 473(1):157-60. PubMed ID: 3264745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of L-vesamicol, an inhibitor of vesicular acetylcholine uptake, on two populations of miniature endplate currents at the snake neuromuscular junction.
    Searl T; Prior C; Marshall IG
    Neuroscience; 1990; 35(1):145-56. PubMed ID: 2141672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of alteration of nerve terminal Ca2+ regulation on increased spontaneous quantal release of acetylcholine by methyl mercury.
    Levesque PC; Atchison WD
    Toxicol Appl Pharmacol; 1988 Jun; 94(1):55-65. PubMed ID: 3376114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes of quantal transmitter release caused by gadolinium ions at the frog neuromuscular junction.
    Molgó J; del Pozo E; Baños JE; Angaut-Petit D
    Br J Pharmacol; 1991 Sep; 104(1):133-8. PubMed ID: 1686201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dihydropyridine-sensitive and -insensitive components of acetylcholine release from rat motor nerve terminals.
    Atchison WD
    J Pharmacol Exp Ther; 1989 Nov; 251(2):672-8. PubMed ID: 2478694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nicotinic agonists antagonize quantal size increases and evoked release at frog neuromuscular junction.
    Van der Kloot W
    J Physiol; 1993 Aug; 468():567-89. PubMed ID: 8254525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Passive transfer of Lambert-Eaton syndrome to mice induces dihydropyridine sensitivity of neuromuscular transmission.
    Flink MT; Atchison WD
    J Physiol; 2002 Sep; 543(Pt 2):567-76. PubMed ID: 12205190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muscarinic inhibition of quantal transmitter release from the magnesium-paralysed frog sartorius muscle.
    Arenson MS
    Neuroscience; 1989; 30(3):827-36. PubMed ID: 2788830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spontaneous acetylcholine release in mammalian neuromuscular junctions.
    Losavio A; Muchnik S
    Am J Physiol; 1997 Dec; 273(6):C1835-41. PubMed ID: 9435487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coupling of L-type calcium channels to neurotransmitter release at mouse motor nerve terminals.
    Urbano FJ; Depetris RS; Uchitel OD
    Pflugers Arch; 2001 Mar; 441(6):824-31. PubMed ID: 11316267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The upregulation of acetylcholine release at endplates of alpha-bungarotoxin-treated rats: its dependency on calcium.
    Plomp JJ; van Kempen GT; Molenaar PC
    J Physiol; 1994 Jul; 478 ( Pt 1)(Pt 1):125-36. PubMed ID: 7965828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in miniature endplate potential frequency during repetitive nerve stimulation in the presence of Ca2+, Ba2+, and Sr2+ at the frog neuromuscular junction.
    Zengel JE; Magleby KL
    J Gen Physiol; 1981 May; 77(5):503-29. PubMed ID: 6262429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of glutamate- and adenosine-induced decrease of acetylcholine quantal release at frog neuromuscular junction.
    Adámek S; Shakirzyanova AV; Malomouzh AI; Naumenko NV; Vyskočil F
    Physiol Res; 2010; 59(5):803-810. PubMed ID: 21142401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylmercury-induced depression of neuromuscular transmission in the rat.
    Atchison WD; Narahashi T
    Neurotoxicology; 1982 Nov; 3(3):37-50. PubMed ID: 6298679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions of mitochondrial inhibitors with methylmercury on spontaneous quantal release of acetylcholine.
    Levesque PC; Atchison WD
    Toxicol Appl Pharmacol; 1987 Feb; 87(2):315-24. PubMed ID: 2435022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Ca2+ channel blockers on transmitter release and presynaptic currents at the frog neuromuscular junction.
    Katz E; Ferro PA; Cherksey BD; Sugimori M; Llinás R; Uchitel OD
    J Physiol; 1995 Aug; 486 ( Pt 3)(Pt 3):695-706. PubMed ID: 7473230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acetylcholine release at neuromuscular junctions of adult tottering mice is controlled by N-(cav2.2) and R-type (cav2.3) but not L-type (cav1.2) Ca2+ channels.
    Pardo NE; Hajela RK; Atchison WD
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1009-20. PubMed ID: 16982704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.